Skip to search formSkip to main contentSkip to account menu

Schedule III Substance

Known as: C-III, CIII, SPL DEA Schedule III 
A category of drugs that have less potential for abuse or addiction than Schedule I or II drugs and have a useful medical purpose.
National Institutes of Health

Related topics

Related topics

1 relation
Structured Product Labeling DEA Schedule Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
PROTEINS, GROWTH FACTORS, AND PROGRESSION OF KIDNEY DISEASE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTORS IN DIABETIC NEPHROPATHY: EXPRESSION STUDIES IN BIOPSIES OF TYPE 2 DIABETIC…
Vascular endothelial growth factor (VEGF) is involved in the pathogenesis of diabetic retinopathy but its role in diabetic… 
1998
1998
Omega- 3 Ethyl Ester Concentrate Decreases Total Apolipoprotein CIII and Increases Antithrombin III in Postmyocardial Infarction Patients
SummaryThis study investigated whether an ethyl ester preparation of fish oil (ω-3) could normalise raised plasma concentrations… 
1998
1998
Linkage of the apo CIII microsatellite with isolated low high-density lipoprotein cholesterol
To evaluate whether a highly polymorphic mic-rosatellite region within intron 3 of the apolipoprotein (apo) CIII gene is linked… 
1996
1996
Asymmetric catalysis, CIII: EnantioselectiveMichael addition of 1,3-dicarbonyl compounds to conjugated nitroalkenes
SummaryOptically activeMichael adducts were synthesized by addition of 1,3-dicarbonyl compounds to conjugated nitroalkenes. Good… 
1991
1991
The activity of the CIII regulator of lambdoid bacteriophages resides within a 24-amino acid protein domain.
The CIII protein of lambdoid bacteriophages promotes lysogeny by stabilizing the phage-encoded CII protein, a transcriptional… 
1990
1990
Primary structure of the bovine analogues to human apolipoproteins CII and CIII. Studies on isoforms and evidence for proteolytic processing.
Two major isoforms of the bovine analogue to human apolipoprotein (apo) CII were purified from plasma. They were both as… 
1989
1989
Study of DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in patients with peripheral arterial disease.
1. We have determined the frequency of DNA polymorphisms of the human apolipoprotein AI-CIII-AIV gene cluster, detected with XmnI… 
1987
1987
Study of the cardiovascular effects of clenbuterol in exercise-induced asthma.
The protective effect of clenbuterol on exercise-induced asthma was studied in 14 patients with aspecific bronchial… 
1986
1986
Polymorphisms in the apolipoprotein AI-CIII gene complex.
We report the presence of five restriction fragment length polymorphisms in the apolipoprotein AI-CIII (apo AI-CIII) gene complex… 
Highly Cited
1976
Highly Cited
1976
The synthesis of apoproteins of very low density lipoproteins isolated from the Golgi apparatus of rat liver.
The incorporation of [3H]leucine in vivo into very low density lipoproteins (VLDL) from the rat hepatic Golgi apparatus and serum… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)